Related references
Note: Only part of the references are listed.Two Phase 1, Open-Label, Single-Dose, Randomized, Crossover Studies to Assess the Pharmacokinetics, Safety, and Tolerability of Orally Administered Granules of Secnidazole (2 g) in Healthy Female Volunteers Under Different Administration Conditions
Helen S. Pentikis et al.
CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT (2018)
Lack of a Pharmacokinetic Interaction Between SYM-1219 Granules Containing 2 Grams of Secnidazole and a Combined Oral Contraceptive in a Phase 1, Randomized, Open-Label Study in Healthy Female Volunteers
Helen S. Pentikis et al.
ADVANCES IN THERAPY (2017)
Secnidazole Treatment of Bacterial Vaginosis A Randomized Controlled Trial
Sharon L. Hillier et al.
OBSTETRICS AND GYNECOLOGY (2017)
A review of the pharmacokinetic properties of SYM-1219, a single oral dose granule formulation containing 2 g of secnidazole, for the treatment of bacterial vaginosis
H. Pentikis et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Susceptibility of trichomonas vaginalis clinical isolates to secnidazole and metronidazole
A. Ghosh et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
A post hoc analysis of secnidazole 2 g for the treatment of bacterial vaginosis: effect of 2016 FDA guidance on clinical response rates in a subpopulation of patients
P. Nyirjesy et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
A phase-3, double-blind, placebo-controlled study of the effectiveness and safety of single oral doses of secnidazole 2 g for the treatment of women with bacterial vaginosis
Jane R. Schwebke et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Susceptibility of bacterial vaginosis (BV)-associated bacteria to secnidazole compared to metronidazole, tinidazole and clindamycin
Melinda A. B. Petrina et al.
ANAEROBE (2017)
Efficacy of the Mentha crispa in the treatment of women with Trichomonas vaginalis infection
Maria Elisabete A. Moraes et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2012)
A comparative study of oral single dose of metronidazole, tinidazole, secnidazole and ornidazole in bacterial vaginosis
Jyoti Thulkar et al.
INDIAN JOURNAL OF PHARMACOLOGY (2012)
Altered Vaginal Microbiota Are Associated With Perinatal Mother-to-Child Transmission of HIV in African Women From Burkina Faso
Daniel N. Frank et al.
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES (2012)
Bacterial Vaginosis Associated with Increased Risk of Female-to-Male HIV-1 Transmission: A Prospective Cohort Analysis among African Couples
Craig R. Cohen et al.
PLOS MEDICINE (2012)
Trichomonas vaginalis Antimicrobial Drug Resistance in 6 US Cities, STD Surveillance Network, 2009-2010
Robert D. Kirkcaldy et al.
EMERGING INFECTIOUS DISEASES (2012)
Treatment of abnormal vaginal flora in early pregnancy with clindamycin for the prevention of spontaneous preterm birth: a systematic review and metaanalysis
Ronald F. Lamont et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2011)
Interpreting the epidemiology and natural history of bacterial vaginosis: Are we still confused?
Jeanne M. Marrazzo
ANAEROBE (2011)
Bacterial vaginosis is associated with uterine cervical human papillomavirus infection: a meta-analysis
Evy Gillet et al.
BMC INFECTIOUS DISEASES (2011)
Evaluation of the therapeutic efficacy of Mentha crispa in the treatment of giardiasis
Naracelia S. B. Teles et al.
CONTEMPORARY CLINICAL TRIALS (2011)
Prevalence of Bacterial Vaginosis and Vulvovaginal Candidiasis Mixed Infection in a Southeastern American STD Clinic
Charles A. Rivers et al.
SEXUALLY TRANSMITTED DISEASES (2011)
In vitro activity of secnidazole against Atopobium vaginae, an anaerobic pathogen involved in bacterial vaginosis
E. De Backer et al.
CLINICAL MICROBIOLOGY AND INFECTION (2010)
Bacterial Vaginosis Assessed by Gram Stain and Diminished Colonization Resistance to Incident Gonococcal, Chlamydial, and Trichomonal Genital Infection
Rebecca M. Brotman et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Bacterial Vaginosis: Are We Coming Full Circle?
Jane R. Schwebke
JOURNAL OF INFECTIOUS DISEASES (2009)
Bacterial vaginosis and HIV acquisition: a meta-analysis of published studies
Julius Atashili et al.
AIDS (2008)
Relationship of specific vaginal bacteria and bacterial vaginosis treatment failure in women who have sex with women
Jeanne M. Marrazzo et al.
ANNALS OF INTERNAL MEDICINE (2008)
Viral sexually transmitted infections and bacterial vaginosis: 2001-2004 national health and nutrition examination survey data
Jenifer E. Allsworth et al.
SEXUALLY TRANSMITTED DISEASES (2008)
A randomized trial of metronidazole in asymptomatic bacterial vaginosis to prevent acquisition of sexually transmitted diseases
Jane R. Schwebke et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2007)
Determination of secnidazole in human plasma by high-performance liquid chromatography with UV detection and its application to the bioequivalence studies
Xiaoyu Li et al.
BIOMEDICAL CHROMATOGRAPHY (2007)
The International Infections in Pregnancy (IIP) study:: Variations in the prevalence of bacterial vaginosis and distribution of morphotypes in vaginal smears among pregnant women
Jorge E. Tolosa et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
High recurrence rates of bacterial vaginosis over the course of 12 months after oral metronidazole therapy and factors associated with recurrence
CS Bradshaw et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
Short-term therapy for mixed vaginal infections
R Villagrana-Zesati et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2006)
Molecular identification of bacteria associated with bacterial vaginosis
DN Fredricks et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
A cluster analysis of bacterial vaginosis-associated microflora and pelvic inflammatory disease
RB Ness et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Low-dose secnidazole in the treatment of bacterial vaginosis
JT Núñez et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2005)
Bacterial vaginosis and anaerobic bacteria are associated with endometritis
CL Haggerty et al.
CLINICAL INFECTIOUS DISEASES (2004)
Personal digital assistants used to document compliance of bacterial vaginosis treatment
JB Bartley et al.
SEXUALLY TRANSMITTED DISEASES (2004)
Antimicrobial resistance associated with the treatment of bacterial vaginosis
RH Beigi et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2004)
Treatment of asymptomatic bacterial vaginosis to prevent pre-term delivery: a randomised trial
S Guaschino et al.
EUROPEAN JOURNAL OF OBSTETRICS GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2003)
Association between acquisition of herpes simplex virus type 2 in women and bacterial vaginosis
TL Cherpes et al.
CLINICAL INFECTIOUS DISEASES (2003)
Bacterial vaginosis as a risk factor for preterm delivery: A meta-analysis
H Leitich et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2003)
A randomized trial comparing mebendazole and secnidazole for the treatment of giardiasis
AA Escobedo et al.
ANNALS OF TROPICAL MEDICINE AND PARASITOLOGY (2003)
Gynecologic consequences of bacterial vaginosis
JR Schwebke
OBSTETRICS AND GYNECOLOGY CLINICS OF NORTH AMERICA (2003)
Vaginal Lactobacillus flora of healthy Swedish women
A Vásquez et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2002)
Factors associated with acquisition of, or persistent colonization by, vaginal lactobacilli: Role of hydrogen peroxide production
AC Vallor et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
Efficacy and safety of quinfamide versus secnidazole in the management of amoebic non-dysenteric colitis in children
N Padilla et al.
CLINICAL DRUG INVESTIGATION (2000)
Metronidazole to prevent preterm delivery in pregnant women with asymptomatic bacterial vaginosis.
JC Carey et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
